GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (TSXV:LBL.H) » Definitions » YoY Rev. per Sh. Growth

Lattice Biologics (TSXV:LBL.H) YoY Rev. per Sh. Growth : -100.00% (As of Jun. 2021)


View and export this data going back to 1995. Start your Free Trial

What is Lattice Biologics YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Lattice Biologics's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2021 was -100.00%.

Lattice Biologics's Revenue per Share for the three months ended in Jun. 2021 was C$0.00.


Lattice Biologics YoY Rev. per Sh. Growth Historical Data

The historical data trend for Lattice Biologics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics YoY Rev. per Sh. Growth Chart

Lattice Biologics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Sep16 Sep17 Sep18 Sep19 Sep20
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -58.25 -62.79 93.75 3.23

Lattice Biologics Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.67 28.57 -50.00 -57.14 -100.00

Lattice Biologics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Lattice Biologics's YoY Rev. per Sh. Growth for the fiscal year that ended in Sep. 2020 is calculated as:

YoY Rev. per Sh. Growth (A: Sep. 2020 )
=(Revenue per Share (A: Sep. 2020 )-Revenue per Share (A: Sep. 2019 ))/ | Revenue per Share (A: Sep. 2019 ) |
=(0.032-0.031)/ | 0.031 |
=3.23 %

Lattice Biologics's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2021 is calculated as:

YoY Rev. per Sh. Growth (Q: Jun. 2021 )
=(Revenue per Share (Q: Jun. 2021 )-Revenue per Share (Q: Jun. 2020 )) / | Revenue per Share (Q: Jun. 2020 )) |
=(0-0.007)/ | 0.007 |
=-100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lattice Biologics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Lattice Biologics (TSXV:LBL.H) Business Description

Traded in Other Exchanges
N/A
Address
512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (TSXV:LBL.H) Headlines

No Headlines